3D Systems (DDD) said Wednesday that it has received the US Food and Drug Administration's 510(k) clearance for its 3D printed Patient-Matched Guides, developed in partnership with Smith+Nephew for use in ankle replacement surgeries.
510(k) clearance indicates that the FDA has determined the device to be safe and effective by comparing it to a legally marketed device already on the market, allowing it to be sold in the US, according to the FDA's website.
Price: 1.9500, Change: -0.01, Percent Change: -0.51
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.